Genomics of renal cell cancer-- does it provide breakthrough? (Q36428987)

14 August 2017

1 reference

title

Genomics of renal cell cancer-- does it provide breakthrough? (English)

1 reference

14 August 2017

0 references

László Kopper

1

1 reference

PubMed ID

16554910

14 August 2017

József Tímár

series ordinal

2

1 reference

14 August 2017

23 March 2006

1 reference

Pathology Oncology Research

14 August 2017

1 reference

14 August 2017

12

1 reference

14 August 2017

1

1 reference

14 August 2017

5-11

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02893425

14 August 2017

0 references

cites work

Leukocyte orchestration in blood and tumour tissue following interleukin-2 based immunotherapy in metastatic renal cell carcinoma.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02893425

Preclinical and clinical evaluations of ABX-EGF, a fully human anti-epidermal growth factor receptor antibody

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02893425

Renal cell carcinoma (RCC) and telomerase activity: relationship to stage

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02893425

Increased mRNA expression of ADAMs in renal cell carcinoma and their association with clinical outcome.

21 January 2018

1 reference

12 December 2020

A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma.

1 reference

12 December 2020

Cadherin-6: a new prognostic marker for renal cell carcinoma

1 reference

12 December 2020

Disease-associated expression profiles in peripheral blood mononuclear cells from patients with advanced renal cell carcinoma.

1 reference

12 December 2020

Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array

1 reference

12 December 2020

The systemic inflammatory response, performance status and survival in patients undergoing alpha-interferon treatment for advanced renal cancer

1 reference

12 December 2020

Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: exploiting the hypoxia-induced pathway.

1 reference

12 December 2020

Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor.

1 reference

12 December 2020

Steroid hormone receptor expression in renal cell carcinoma: an immunohistochemical analysis of 182 tumors

1 reference

12 December 2020

Epidermal growth factor receptor and epidermal growth factor receptor therapies in renal cell carcinoma: do we need a better mouse trap?

1 reference

12 December 2020

The Heidelberg classification of renal cell tumours.

1 reference

12 December 2020

The sensitivity of renal cell carcinoma cells to interferon alpha correlates with p53-induction and involves Bax.

1 reference

12 December 2020

Genetic basis of cancer of the kidney: disease-specific approaches to therapy.

1 reference

12 December 2020

Epidermal growth factor receptor expression is associated with rapid tumor cell proliferation in renal cell carcinoma

1 reference

12 December 2020

Is treatment with interferon-alpha effective in all patients with metastatic renal carcinoma? A new approach to the investigation of interactions

1 reference

12 December 2020

Alterations of microvascular density in bone metastases of adenocarcinomas

1 reference

12 December 2020

Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma

1 reference

12 December 2020

Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification

1 reference

12 December 2020

Microarray gene expression profiling and analysis in renal cell carcinoma

1 reference

12 December 2020

The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma

1 reference

12 December 2020

Immunohistochemical analysis of tumor polyamines discriminates high-risk patients undergoing nephrectomy for renal cell carcinoma

1 reference

12 December 2020

Searching for the hereditary causes of renal-cell carcinoma

1 reference

12 December 2020

Revealing urologic diseases by proteomic techniques

1 reference

12 December 2020

The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer.

1 reference

12 December 2020

Targeted agents for the treatment of advanced renal cell carcinoma

1 reference

12 December 2020

The level of cadherin-6 mRNA in peripheral blood is associated with the site of metastasis and with the subsequent occurrence of metastases in renal cell carcinoma

1 reference

12 December 2020

Prognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma

1 reference

12 December 2020

Prognostic factors of immunotherapy in metastatic renal cell carcinoma

1 reference

12 December 2020

HLA-class-I and -class-II expression on renal tumor xenografts and the relation to sensitivity for alpha-IFN, gamma-IFN and TNF.

1 reference

12 December 2020

Expression of vascular endothelial growth factor protein in human renal cell carcinoma

1 reference

12 December 2020

Molecular differential pathology of renal cell tumours

1 reference

12 December 2020

Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6--from the Groupe Francais d'Immunotherapie

1 reference

12 December 2020

Gene expression profiling of renal cell carcinoma

1 reference

12 December 2020

Prognostic value of uPA, PAI-1, and DNA content in adult renal cell carcinoma

1 reference

12 December 2020

Using protein expressions to predict survival in clear cell renal carcinoma

1 reference

12 December 2020

Sorafenib: scientific rationales for single-agent and combination therapy in clear-cell renal cell carcinoma

1 reference

12 December 2020

EGFR mRNA is upregulated, but somatic mutations of the gene are hardly found in renal cell carcinoma in Japanese patients.

1 reference

12 December 2020

C-kit expression in sarcomatoid renal cell carcinoma: potential therapy with imatinib.

1 reference

12 December 2020

Caveolin-1 overexpression predicts poor disease-free survival of patients with clinically confined renal cell carcinoma

1 reference

12 December 2020

XIAP expression is an independent prognostic marker in clear-cell renal carcinomas.

1 reference

12 December 2020

Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy

1 reference

12 December 2020

Prognostic value of carbonic anhydrase IX and KI67 as predictors of survival for renal clear cell carcinoma

1 reference

12 December 2020

Treatment options in metastatic renal carcinoma: an embarrassment of riches

1 reference

12 December 2020

A phase II trial of gefitinib (Iressa, ZD1839) in stage IV and recurrent renal cell carcinoma

1 reference

12 December 2020

Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.

1 reference

12 December 2020

Tissue array-based predictions of pathobiology, prognosis, and response to treatment for renal cell carcinoma therapy

1 reference

12 December 2020

The impact of angiogenesis on the prognosis of advanced renal cell carcinomas.

1 reference

12 December 2020

Are heterogenous results of EGFR immunoreactivity in renal cell carcinoma related to non-standardised criteria for staining evaluation?

1 reference

12 December 2020

Increased expression of caveolin-1 and microvessel density correlates with metastasis and poor prognosis in clear cell renal cell carcinoma

1 reference

12 December 2020

Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL.

1 reference

12 December 2020

The growing family of hereditary renal cell carcinoma

1 reference

12 December 2020

Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma

1 reference

12 December 2020

Genomic alterations in renal tumours: what have we learned in the era of comparative genomic hybridisation?

1 reference

12 December 2020

Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02893425

1 reference

14 August 2017

1 reference

PubMed ID

16554910